Seeking Alpha
 

Bio-Reference Laboratories, Inc. (BRLI)

- NASDAQ
  • Aug. 21, 2013, 12:27 PM
    • BioReference Laboratories (BRLI -0.4%) says its wholly-owned clinical diagnostic sequencing laboratory, GeneDx, is acquiring Edge BioSystems CLIA and its related assets, which are primarily a genetic sequencing service business in Gaithersburg, Maryland.
    • The acquisition will include sequencing equipment and capabilities that are expected to enhance the ability of GeneDx to maintain and improve its position as a premier provider of clinical genetic sequencing services.
    • Terms of the deal were not disclosed.
    | Comment!
Visit Seeking Alpha's
BRLI vs. ETF Alternatives
Company Description
Bio-Reference Laboratories Inc is engaged in providing laboratory testing services. The Company offers chemical diagnostic tests including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis and toxicology.